SARS-CoV-2 infection in pregnant women and their newborns
Auteurs & affiliatie
Melanie Etti, Musa Sekikubo, Victoria Nankabirwa, Halvor Sommerfelt, Bridget Freyne, Kondwani Kawaza, Gladys Gadama, Kondwani Jambo, Esperança Sevene, Marleen Temmerman, Laura A. Magee, Peter von Dadelszen, Asma Khalil, Kirsty Le Doare
There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in conjunction with the WHO/HRP Alliance, plans to address these knowledge gaps by harnessing research infrastructures in place in five sub-Saharan African countries in order to screen more than 50,000 pregnant women and their infants for SARS-CoV-2, while monitoring pregnancy and neonatal outcomes. We anticipate that the results of this study will provide much needed information about the risks that SARS-CoV-2 poses to pregnant women and their babies, as well as establishing potential routes of mother-to-child transmission.
Olivier Degomme, Anna Galle, Ines Keygnaert, Anne Nobels, Emilomo Ogbe2010 Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers
Stanley Luchters2014 Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya
Olivier Degomme, Kristien Michielsen, Heleen Vermandere